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Abstract: Benzoylformate decarboxylase (BFDC) and pyruvate decarboxylase (PDC) are
thiamin diphosphate-dependent enzymes that share some structural and mechanistic similarities.
Both enzymes catalyze the nonoxidative decarboxylation of 2-keto acids, yet differ considerably
in their substrate specificity. In particular, the BFDC from P. putida exhibits very limited
activity with pyruvate, whereas the PDCs from S. cerevisiae or from Z. mobilis show virtually no
activity with benzoylformate (phenylglyoxylate). Previously, saturation mutagenesis was used to
generate the BFDC T377L/A460Y variant, which exhibited a greater than 10,000-fold increase in
pyruvate/benzoylformate substrate utilization ratio compared to that of wtBFDC. Much of this change
could be attributed to an improvement in the Km value for pyruvate and, concomitantly, a decrease in
the kcat value for benzoylformate. However, the steady-state data did not provide any details about
changes in individual catalytic steps. To gain insight into the changes in conversion rates of pyruvate
and benzoylformate to acetaldehyde and benzaldehyde, respectively, by the BFDC T377L/A460Y
variant, reaction intermediates of both substrates were analyzed by NMR and microscopic rate
constants for the elementary catalytic steps were calculated. Herein we also report the high resolution
X-ray structure of the BFDC T377L/A460Y variant, which provides context for the observed changes
in substrate specificity.
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1. Introduction
The decarboxylases form the largest group of thiamin diphosphate (ThDP)-dependent enzymes [1].
The archetypal member of this group is pyruvate decarboxylase (PDC), which catalyzes the
nonoxidative decarboxylation of pyruvate to yield acetaldehyde and carbon dioxide, a reaction
critical to the fermentation pathway of several yeast and bacteria [2]. X-ray structures of PDCs from
a variety of species show that, in addition to ThDP, the active site contains two ionizable acidic
residues as well as two contiguous histidine residues that are located on an ordered loop [3–6].
The latter has been termed the HH-motif, and mutagenesis and kinetic studies have revealed that both
histidines play significant roles in catalysis [7–10]. X-ray structures of several other ThDP-dependent
decarboxylases reveal that, even though a variety of residues may line the substrate-binding pocket,
thereby explaining the observed differences in substrate specificity, most possess the HH-motif and
the two acidic residues [11–13].
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Benzoylformate decarboxylase (BFDC) is the penultimate enzyme in the mandelate pathway,
a secondary metabolic pathway that allows various pseudomonads to grow using R-mandelate as
their only source of carbon [14–16]. Also a ThDP-dependent enzyme, BFDC catalyzes the nonoxidative
decarboxylation of benzoylformate, generating benzaldehyde and carbon dioxide [14]. Given the
similarity of their reactions, and their using the same cofactor, it may have been expected that the
active sites of PDC and BFDC would be similar. However, this proved not to be the case, for the
active site of BFDC was found to contain two leucine residues occupying positions equivalent to the
HH-motif [17]. That said, the active site of BFDC does contain two histidine residues (His70 and
His281) and mutagenesis studies suggest that they too are catalytically important [18,19]. Another
difference was that the BFDC active site lacked the two acidic residues found in the HH-motif family.
Instead, BFDC’s only other ionizable residue is a serine, Ser26, which has also been implicated in the
catalytic mechanism [18].
Although their active sites and substrate preference may differ, the catalytic cycles of BFDC
and PDC can still be broken into the same series of steps (Scheme 1) [20]. The first two steps are
the deprotonation of the C2 carbon of ThDP to generate either an ylid [16,21,22] or a carbene [23],
followed by non-covalent binding of the 2-keto substrate to provide the Michaelis complex. Addition
of the C2 carbanion/carbene of ThDP to the carbonyl of the substrate gives rise to the first
covalent tetrahedral intermediate, which subsequently loses carbon dioxide resulting in the formation
of carbanion/enamine intermediate typical of all ThDP-dependent enzymes. In decarboxylases
such as BFDC and PDC, protonation of this enamine generates a second tetrahedral intermediate,
which finally breaks down, releasing the product aldehyde and regenerating ThDP.
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Scheme 1. Mechanism of benzoylformate decarboxylase (BFDC) and pyruvate decarboxylase (PDC)
with intermediates and net rate constants.
Over the past few years, the steady-state distribution of the covalent intermediates has been used
to determine net rate constants for the elementary catalytic steps of several ThDP-dependent enzymes
including PDC [24] and BFDC [25]. For the former, decarboxylation and product release were found
to be partially rate-limiting, but formation of lactyl-ThDP (LThDP), the first covalent intermediate,
was quite rapid [24]. Conversely, the rate-limiting step for BFDC was found to be the formation
of the first covalent intermediate, mandelyl-ThDP (MThDP) [18,25]. Further, BFDC was found to
d carboxylate its first covalent adduct an order of magnitude faster than any other ThDP-dependent
enzyme studied to date [25].
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As with many ThDP-dependent decarboxylases, BFDC and PDC are both are capable of
stereoselective carboligation reactions leading to chiral α-hydroxy ketones [26]. These have been used
as versatile building blocks in the pharmaceutical (and other) industries [26–28]. As a consequence
there is considerable interest in expanding the capabilities of the decarboxylases to accept alternative
substrates. While both BFDC and PDC exhibit some substrate promiscuity neither enzyme is
particularly efficient at decarboxylating the other’s in vivo substrate [29]. Recently, as part of our
ongoing efforts to understand the evolution of substrate specificity in ThDP-dependent enzymes,
we used site-saturation mutagenesis in an attempt to convert a BFDC into a PDC [30]. The BFDC
T377L/A460Y variant was observed during screening to have greatly enhanced PDC activity.
Subsequently it was shown to have a 10,000-fold increase in its substrate utilization ratio between
pyruvate and benzoylformate compared to that of wtBFDC [30].
Here we describe our efforts to identify the reasons for that change in specificity. In the first
instance, we used NMR spectroscopy to analyze the intermediates obtained in the reaction of BFDC
T377L/A460Y with both benzoylformate and pyruvate. The microscopic rate constants were calculated
for the elementary catalytic steps in the reaction of both substrates. Further, in an attempt to understand
the structural basis for the altered substrate specificity exhibited by the T377L/A460Y variant, its high
resolution X-ray structure was determined.
2. Results and Discussion
2.1. Substrate Profile of T377L/A460Y
Our earlier study compared the reactions of wtBFDC, ScPDC and the T377L/A460Y variant only
with benzoylformate and pyruvate. Here the comparison was extended to include a variety of straight-
and branched-chain 2-keto acids, as well as phenylpyruvate (Table 1). The steady-state kinetic constants
for reaction of wtBFDC with pyruvate could only be determined under V/K conditions, i.e., at substrate
concentrations well below the Km value, which was estimated to be easily in excess of 100 mM [30].
By contrast the T377L/A460Y variant has a Km value for pyruvate of 4.6 mM, which is comparable
to the pyruvate S0.5 value for ScPDC. In addition to improving utilization of pyruvate, the double
variant was found to decarboxylate several other aliphatic 2-keto acids at a faster rate than wtBFDC.
While it was most efficient with 2-ketohexanoate and 4-methylthio-2-ketobutanoate as substrates,
there was only a 60-fold difference in kcat/Km values between the best substrate, 2-ketohexanoate,
and its least efficient substrate, pyruvate. In many ways pyruvate is still the exception as its Km value
was significantly higher than those of other aliphatic substrates. With regards to kcat, there is less than a
15-fold decrease between the substrate that is turned over the fastest, 3-methyl-2-ketopentanoate,
and the substrate that the T377L/A460Y variant decarboxylates the slowest, 2-ketopentanoate.
With the exception of benzoylformate, the T377L/A460Y variant was able to decarboxylate its
substrates more efficiently than wtBFDC. Similarly, only pyruvate and its longer chain analogues,
2-ketobutanoate and 2-ketopentanoate were better substrates for ScPDC.
Overall, the data in Table 1 clearly demonstrate that the T377L/A460Y variant is able to
decarboxylate a wide range of aliphatic substrates and, in most cases, more efficiently that either
wtBFDC or ScPDC. That said, it is also apparent that the ability of this variant to decarboxylate
either benzoylformate or pyruvate is considerably less than that of wtBFDC or ScPDC, respectively.
The similarity of substrate Km values suggests that substrate binding is not likely to be the issue,
rather the changes in active site geometry are having a significant effect on one or more of the
individual catalytic steps.
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Table 1. Kinetic characterization of wtBFDC, BFDC T377L/A460Y and ScPDC at pH 6.0 a.
Substrate
wtBFDC BFDC T377L/A460Y ScPDC
Km (mM) kcat (s−1)
kcat/Km
(mM−1·s−1) Km (mM) kcat (s−1)
kcat/Km
(mM−1·s−1) S0.5 (mM) kcat (s−1)
kcat/S0.5
(mM−1·s−1)
Benzoylformate 0.27 ± 0.02 320 ± 4 1180 0.45 ± 0.04 15 ± 1 34 NAD b NAD b NAD b
Pyruvate - - 0.01 4.6 ± 0.3 3.3 ± 0.1 0.72 1.3 ± 0.1 60 ± 2 45
4-Methylthio-2-ketobutanoate 1.3 ± 0.2 4.5 ± 0.3 3.5 0.14 ± 0.01 4.6 ± 0.1 33 0.80 ± 0.05 5.2 ± 0.3 6.6
2-Ketohexanoate 5.3 ± 0.3 4.1 ± 0.1 1.3 0.14 ± 0.01 5.9 ± 0.2 42 1.5 ± 0.1 15 ± 1 9.8
2-Ketopentanoate 11 ± 1 6.0 ± 0.5 1.8 0.15 ± 0.01 1.1 ± 0.1 7.5 1.1 ± 0.1 27 ± 2 24
4-Methyl-2-ketopentanoate 9.6 c 11 c 1.1 c 0.14 ± 0.02 2.7 ± 0.2 20 5.0 ± 0.2 10 ± 1 2.0
3-Methyl-2-ketopentanoate - - 1.6 b 1.2 ± 0.1 16 ± 1 13 8.7 ± 0.5 22 ± 1 2.5
2-Ketobutanoate 4.1 ± 0.1 7.5 ± 0.6 0.5 0.39 ± 0.02 6.0 ± 0.1 16 0.49 ± 0.02 25 ± 1 49
3-Methyl-2-ketobutanoate - - 2.6 c,d 0.77 ± 0.06 12 ± 1 15 0.73 ± 0.03 6.3 ± 0.2 8.6
Phenylpyruvate 0.1 c,d 0.82 ± 0.06 2.0 ± 0.1 2.5 0.23 ± 0.01 0.87 ± 0.02 3.7
a Reactions were carried out in 100 mM KPO4 buffer containing 1 mM MgSO4 and 0.5 mM ThDP. Values are the mean of three independent determinations ± standard error;
b NAD, no activity detected; c Data from Siegert et al. [29]; d Specific activity determined at a substrate concentration of 20 mM.
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2.2. Intermediate Distribution Analysis for Reaction of T377L/A460Y with Benzoylformate
To explore this possibility the microscopic rate constants for the BFDC T377L/A460Y variant were
determined for the decarboxylation of both benzoylformate and pyruvate. These have been determined
previously for the reaction of wtBFDC with benzoylformate [25]. In that study it was shown that
the rate-limiting step was the formation of MThDP by addition of the ThDP ylid to benzoylformate,
and that BFDC carried out its decarboxylation step at least two orders of magnitude faster than any
other ThDP-dependent enzyme [25].
All three major intermediates, unreacted ThDP, MThDP, and 2-hydroxybenzyl-ThDP (HBzThDP),
can be detected at steady-state when T377L/A460Y reacts with benzoylformate (Figure 1).
While the MThDP signal is close to the limits of resolution, it is clearly visible. Following correction for
non-enzymatic decarboxylation of MThDP [25] analysis reveals that ~37% of the active sites contain
C2-unsubstituted ThDP and 3% contain MThDP. The remaining 60% are occupied by HBzThDP.
This is distinctly different to the result obtained with wtBFDC where a similar analysis provided values
of 79%, 3% and 18% for ThDP, MThDP and HBzThDP, respectively [25]. A comparison of the derived
kinetic constants for wtBFDC and T377L/A460Y can be seen in Table 2. In wtBFDC addition of the
ThDP ylid to benzoylformate (i.e., C–C formation, k2′) is clearly rate limiting. Conversely, protonation
of the enamine/elimination of benzaldehyde (k4′) has been reduced ~100-fold in the T377L/A460Y
variant and has now become rate limiting. It is notable that for both variants decarboxylation of
MThDP (k3′) is significantly faster than other steps in the reaction (Table 2). Further, even though the
rate for T377L/A460Y has decreased considerably compared to that of the wild-type enzyme it is still
faster than decarboxylation of LThDP by pyruvate-utilizing enzymes [20,31,32].
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Figure 1. The 2′-CH3 and 4-CH3 singlet signals of thiamin diphosphate (ThDP) and of
benzoylformate-conjugated covalent intermediates were used for the assignment and quantitative
analysis of the following intermediates: ThDP (2.64 and 2.57 ppm), mandelyl-ThDP (MThDP) (2.48 and
2.41 ppm), and 2-hydroxybenzyl-ThDP (HBzThDP) (2.45 and 2.40 ppm). Intermediates and cofactor
were isolated from the protein by acid quench after a reaction time of 1 s and analyzed by 1H NMR at
pH 0.75 at 25 ◦C as described in Materials and Methods. Relative concentrations of intermediates were
determined from the relative integrals of the corresponding signals, which were used to calculate all
microscopic rate constants of the catalytic cycle.
2.3. Intermediate Distribution Analysis for Reaction of T377L/A460Y with Pyruvate
The microscopic rate constants for reaction of wtBFDC with pyruvate could not be determined as
only trace amounts of the reaction intermediates were observable at steady-state using the NMR-based
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approach. This is not surprising as activity of wtBFDC with pyruvate could only be measured under
V/K conditions [30]. The lack of any observable reaction intermediates, coupled with a pyruvate Km
value in excess of 100 mM, indicates that the rate-limiting step is the initial formation of the Michaelis
complex and/or the subsequent C–C bond formation (k2′) that provides LThDP.
For T377LA460Y the steady-state distribution of intermediates showed that, when pyruvate
is used as substrate (Figure 2), all the key catalytic intermediates are present: ThDP, 2-lactyl-ThDP
(LThDP) and 2-hydroxyethyl-ThDP (HEThDP). This finding indicates that all major steps of catalysis
are on the same time scale. In addition to those anticipated intermediates, a minor fraction of
2-acetolactate-ThDP (ALThDP) was observed [31].
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obtained from Joseph et al. [33]; e Values for ZmPDC were obtained from Tittmann et al. [24]. 
ALThDP arises during an off‐pathway reaction in which a second molecule of pyruvate acts as 
the electron acceptor for the post decarboxylation carbanion intermediate. ALThDP has previously 
8.08.18.2 7.17.27.37.4
ThDP
HEThDP
LThDP
ALThDP
1H Chemical shift (ppm)
Figure 2. The C6′-H singlet signals of ThDP (thiamin diphosphate) and of pyruvate-conjugated covalent
intermediates were used for the assignment and quantitative analysis of the following intermediates:
ThDP (8.01 ppm), LThDP (lactyl-ThDP) (7.27 ppm), HEThDP (2-hydroxyethyl-ThDP) (7.34 ppm) and
ALThDP (2-acetolactate-ThDP) (7.30 ppm). Intermediates and cofactor were isolated by acid quench
after a reaction time of 8 s and analyzed by 1H NMR at pH 0.75 at 25 ◦C as described in Materials and
Methods. Relative concentrations of intermediates were determined from the relative integrals of the
corresponding signals, which were used to calculate all microscopic rate constants of the catalytic cycle.
Table 2. Net rate constants (s−1) for reaction of BFDC and PDC variants with benzoylformate
and pyruvate.
Enzyme Variant Substrate kcat C–C (k2 ′) Decarboxylation (k3 ′) Release (k4 ′)
wtBFDC a BF 450 500 16,000 2400Pyruvate <0.05 b NDc ND c ND c
BFDC T377L/A460Y BF 15 40 500 2Pyruvate 3.3 6 24 10
ScPDC d Pyruvate 38 294 105 105
ZmPDC e Pyruvate 150 2650 397 265
a Values for wtBFDC with BF were obtained from Bruning et al. [25]; b Value for wtBFDC with pyruvate was
obtained from Yep and McLeish [30]; c Not determined; d Values for ScPDC were obtained from Joseph et al. [33];
e Values for ZmPDC were obtained from Tittmann et al. [24].
ALThDP arises during an off-pathway reaction in which a second molecule of pyruvate acts as
the electron acceptor for the post decarboxylation carbanion intermediate. ALThDP has previously
been observed during the determination of the microscopic rate constants for acetohydroxyacid acid
synthase [34–36]. The presence of ALThDP during the reaction cycle of the BFDC T377L/A460Y
variant suggests that the reaction may generate acetolactate. However, the only carboligation product
detected was acetoin. While this seems at odds with the presence of ALThDP, Beigi et al. [37] recently
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described an α-hydroxy-β-keto acid rearrangement-decarboxylation reaction in which acetolactate
spontaneously decarboxylates to yield acetoin. Currently, it is unclear if ALThDP decarboxylates to
yield acetoin or if the decarboxylation of acetolactate occurs after it is released. Regardless, it would
seem that the longer lifetime of the pyruvate-derived carbanion/enamine results in an increase in
formation of a carboligation product.
If this off-pathway reaction is ignored, then the calculation of the forward net rate constants is
possible. These are provided in Table 2. Examination of those rate constants shows that C–C bond
formation (k2′) is the slowest step in the reaction of BFDC T377L/A460Y with pyruvate. Further,
while the variant is clearly more efficient in binding pyruvate, the rate constant for the formation of the
LThDP (6 s−1) is still 50- to 400-fold lower than those of the true PDCs. By comparison, decarboxylation
of the LThDP intermediate (k3′) is ca. four-fold faster, and the subsequent steps involving enamine
protonation/product release (k4′) are, at best, partially rate-limiting. These results are in sharp contrast
with those found in previous studies with ZmPDC [24] and ScPDC [33] where formation of LThDP
was the fast step and both decarboxylation and product release were appreciably slower (Table 2).
That said, it is not without precedent, as initial C–C bond formation (k2′) is the slow step in the reaction
of acetohydroxyacid synthase (AHAS) with pyruvate [32]. Finally, it is notable that decarboxylation of
LThDP catalyzed by BFDC T377L/A460Y is the fast step in the overall process, and only approximately
four-fold slower when compared to ScPDC. It seems that, even with a relatively poor substrate,
the active site of BFDC seems to favor decarboxylation over the other reaction steps.
2.4. X-ray Structure of BFDC T377L/A460Y
In an attempt to understand how the BFDC T377L/A460Y variant resulted in a better binding site
for pyruvate and, potentially, to explain the decrease in the rate of decarboxylation of benzoylformate,
the X-ray structure for T377L/A460Y was determined. The structure was solved to a resolution
of 1.56 Å and the coordinates have been deposited with the Protein Data Bank as PDB ID 4MZX.
The refinement statistics are provided in Table 3.
The overall fold was found to be almost identical to that of wtBFDC holoenzyme, and both
the space group and cell dimensions were also the same. There was a RMSD deviation of 0.28 Å
between the BFDC T377L/A460Y variant and wtBFDC enzyme for the Cα atoms of a single monomer.
As previously observed with BFDC structures, the region comprising residues 461–470 had the highest
B-factors found in the protein.
During the initial rounds of refinement, positive electron density adjacent to the C2 atom of the
thiazolium ring was observed when ThDP was modeled into the active site. This was indicative of the
oxidation of ThDP to thiamin thiazolone diphosphate (TZD). Consequently TZD was modeled into the
active site during subsequent rounds of refinement. This oxidation of ThDP to TZD has been observed
previously in BFDC, as well as other ThDP-dependent enzymes, and has been attributed to radiation
damage [38,39]. As seen in several earlier BFDC structures, the diphosphate tail of TZD is coordinated
to Ca2+, rather than Mg2+. Presumably due to its high concentrations in the crystallization buffer,
Mg2+ is often displaced by Ca2+ during the crystallization of BFDC [17,38]. In addition to the cofactors,
electron density indicative of two glycerol molecules was also observed in the asymmetric unit.
One glycerol was H-bonded to the side chains of Arg294 and Asp312, while the second was coordinated
to the oxygen atoms of the backbone carbonyl of Asp477 and the side chain of Gln443. Finally,
a sodium ion was found coordinated between the main chain carbonyl oxygens of Leu118, Arg120,
and Asn117 from two separate monomers at the dimer–dimer interface. The BFDC T377L/A460Y
structure retained the backbone conformation of the wtBFDC enzyme at the points of the mutations,
but, not surprisingly, additional electron density was seen in the difference maps. This density
corresponded to leucine and tyrosine residues at positions 377 and 460, respectively.
Comparison of the active sites of the wtBFDC and the T377L/A460Y variant showed that the
side chain of His281 is displaced by more than 1 Å compared to the wtBFDC holoenzyme (Figure 3).
The only other notable change was Leu110 being found in two rotamer conformations, one of which
Catalysts 2016, 6, 190 8 of 16
had not previously been observed in BFDC or its variants [17,18,25,38,40,41]. The net result was that
the active site was reduced in volume by ~20%.
Table 3. Data, model, and crystallographic statistics for BFDC T377L/A460Y structure a.
Data Collection Statistics BFDC T377L/A460Y (PDB 4MZX)
Beam line APS, GM/CA-CAT, 23 ID-B
Wavelength 1.03 Å
Space group I222
Cell constants a = 80.98 Å; b = 95.56 Å; c = 137.2 Å; α = β = γ = 90◦
Total reflections 75885
Unique reflections 75885
Resolution limit (Å) 1.56
Completeness (%) 99.8 (100)
Redundancy 7.3 (7.2)
I/σI 27.5 (7.3)
Rmerge (%) 5.8 (29)
Refinement statistics
Resolution range (Å) 1.56–19.71
Rfree test set size 2000
Rcryst (%) 11.7
Rfree (%) 15.0
No. Atoms
Total 4547
Protein 4050
Ligand 41
Water 456
Ramachandran
Favored 98
Allowed 2
Outliers 0
B-factors
Protein 15.1
Ligand 18.4
Solvent 26.4
R.m.s. deviations
Bond lengths (Å) 0.017
Bond angles (◦) 1.50
a Value in parentheses are for the highest-resolution shell.
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Figure 3. Superposition of the active sites of wtBFDC (yellow) and the BFDC T377L/A460Y variant
(cyan) reveals a shift in the position of His281 accompanied by multiple conformations of Leu110.
In addition, ThDP was oxidized to thiamin thiazolone diphosphate (TZD). Figure prepared using
PyMOL (Schrödinger, Inc., Portland, OR USA) using data from PDB ID 1BFD (wtBFDC) and 4MZX
(BFDC T377L/A460Y).
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The data in Table 1 show that the Km value of wtBFDC for pyruvate was in excess of 100 mM,
and for the T377L/A460Y variant, the Km value was reduced to <5 mM. Clearly the latter must have a
binding site much better able to accommodate pyruvate. To see how this was achieved we compared
the binding of the LTHDP to PDC and to BFDC T377L/A460Y. Previously, the ZmPDC E473D structure
in complex with LThDP was solved [42]. In this structure the methyl substituent of the lactyl moiety is
within 5 Å of 11 atoms evenly distributed across seven different residues.
Superimposition of the LThDP intermediate on ThDP in the active site of wtBFDC revealed
only three atoms within 5 Å of the methyl group (Figure 4A). By contrast, superimposition of
LThDP on TZD in the T377L/A460Y structure (Figure 4B) shows that this variant now has 10 atoms
contributing to the methyl-binding site. Thus the active site has become more like that of ZmPDC.
There were some differences for, unlike the evenly distributed interactions which make up the ZmPDC
methyl-binding pocket, 7 of the 10 potential interactions in the BFDC T377L/A460Y variant arise from
the engineered residues, Leu377 and Tyr460. This suggests that changes in other active site residues
may be able to further improve pyruvate binding and, potentially, in positioning the “new” substrate
for decarboxylation and subsequent steps.
While this relatively simplistic modeling of LThDP offers an explanation for how the active site of
the T377L/A460Y variant has improved pyruvate binding, there are still several issues to be addressed.
For example, while the active site volume has been reduced by 20% from wtBFDC, the Km value for
benzoylformate is only increased by a factor of two. Indeed, at 0.45 mM, it remains 10-fold lower than
that of pyruvate (Table 2). To understand how this could be achieved, the tetrahedral intermediate
from the reaction of wtBFDC with methyl benzoylphosphonate (MBP) [41] was superimposed on
the TZD in the active site of T377L/A460Y. The MBP-ThDP intermediate is an analogue of MThDP,
thus can be used to get an indication of potential changes in benzoylformate binding.
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Figure 4. (A) wtBFDC (PDB: 1BFD) with LThDP (gray) placed into the active site by superposition of
the LThDP on the corresponding atoms of ThDP. In total, three atoms are within 5 Å of the methyl
group of LThDP; (B) BFDC T377L/A460Y PDB 4MZX) with LThDP (gray) superimposed on TZD.
In total 10 atoms, from four residues, are within 5 Å of the methyl group of LThDP. In both
structures blue lines indicate distances of <5 Å. Figure prepared using PyMOL with LThDP data from
PDB ID 3OE1 [42].
This simple model indicates a potentially severe steric clash between the phenyl group of the
inhibitor and the engineered mutations (Figure 5). The γ-methyl of Leu377 is within <2.5 Å of several
carbon atoms of the phenyl ring of MBP, whereas Tyr460 has a potential edge-to-edge contact with
MBP that is also within <2.5 Å. While this appears to be at odds with the kinetic data indicating only
a modest effect on Km value for benzoylformate, there is structural evidence that wtBFDC is able to
accommodate unnaturally large substrates by slight rotations of active site residues [43]. Therefore it is
not unreasonable to suggest that the side chains of Tyr460 and Leu377 could rotate to avoid or, at least,
ameliorate unfavorable interactions with the MThDP. Equally plausible is that the phenyl group of the
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MThDP could rotate to prevent steric clash with these residues. Either scenario provides a rationale
for the binding of benzoylformate being relatively unaffected.
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Figure 5. BFDC T377L/A460Y with MBP-ThDP (black) placed into the active site. Red lines indicate
distances of <2.5 Å. Superposition carried out with PyMOL as described in Materials and Methods
using MBP-THDP data from PDB ID 3FSJ [41]
Figure 5 may also provide a partial explanation for the reduction in net rate constants for the
decarboxylation of benzoylformate (Table 2). It is clear that some active site rearrangements will be
necessary to avoid potential steric clashes and permit substrate binding. Conceivably, these may make
it more difficult for the ThDP ylid to attack the carbonyl of benzoylformate, thereby explaining the
observed 12-fold decrease in the rate of formation of the MThDP intermediate (k2′).
Figure 3 shows that the mutations have caused modest, but potentially significant changes
in the orientation of Leu110 and His281. Together these changes provide some insight into the
considerable decrease in the observed rate for the decarboxylation of the MThDP intermediate (k3′),
as well as the release of benzaldehyde (Scheme 1). While its precise role in catalysis is not obvious,
mutagenesis and crystallographic data suggest that Leu110 plays a vital role in the mechanism of
BFDC. The L110A mutation results in greater than four-orders of magnitude decrease in kcat/Km,
due to a simultaneous increase in Km and decrease in kcat values [44]. Analysis of the structure of
wtBFDC in complex with MBP indicates that Leu110 may be responsible for positioning the glyoxylate
moiety of benzoylformate [25,41]. In the T377L/A460Y variant, Leu110 adopts multiple conformations
potentially reducing its ability to lock the glyoxylate moiety into the perpendicular arrangement of the
carboxylate group to the thiazolium-C2α bond. This geometry is thought to promote decarboxylation
by allowing maximum overlap of pi electrons of the thiazolium ring and the p-orbital of the scissile
bond [25,45]. The conformation has been observed in the X-ray structures of all the first tetrahedral
intermediates, and intermediate analogues [25,42,46–48]. Further, Ser26 has been proposed to assist in
the decarboxylation step by carrying out a nucleophilic attack on carboxylate group of MThDP [40].
In wtBFDC, not only does the perpendicular arrangement assure maximum orbital overlay, but also
it positions the hydroxyl group of Ser26 within striking distance of the carboxylate group. Taken
together, the alternative conformations of Leu110 observed may help explain the decrease in the rate
of MThDP decarboxylation (k3′).
The net rate constant associated with product release (k4′) incorporates the protonation of the
enamine/carbanion intermediate, as well as the breakdown of the resultant tetrahedral intermediate
and subsequent release of benzaldehyde. The T377L/A460Y variant exhibits a 100-fold decrease in k4',
i.e., the largest decrease of all net rate constants. Mutagenesis studies suggest that His281 is involved in
the protonation of the enamine/carbanion intermediate [18], whereas His70 has been implicated in the
abstraction of the proton from the HBzThDP intermediate, thereby facilitating product release [18,19].
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Since these two steps of the mechanism are incorporated into this single net rate constant, it is difficult
to say which step has been more affected in the T377L/A460Y variant. The X-ray structure shows that
the position of His70 is largely unaffected by the mutations but that there is a 1 Å displacement of the
imidazole ring of His281 (Figure 3). It is conceivable that this change could reduce proton transfer
efficiency, resulting in an increase in the lifetime of the carbanion/enamine. It is well known that the
BFDC H281A variant has been associated with an improvement in carboligation efficiency [49–51],
which was attributed to the longer lifetime of the enamine. It is also notable that an increase in
the lifetime of the carbanion/enamine in ZmPDC gave rise to formation of acetoin/acetolactate [52].
Given that the 1H NMR spectrum of the intermediates in the reaction of T377L/A460Y with pyruvate
(Figure 2) showed the presence of 2-acetolactate-ThDP, it is reasonable to speculate that displacement
of His281 is contributing to the decrease in k4'. That said, there is a clear increase in the steady-state
concentration of HBzThDP, which certainly indicates that its breakdown and product release—i.e., k5'
(Scheme 1)—also must be greatly reduced.
3. Materials and Methods
3.1. Materials
Plasmids containing genes for recombinant alcohol dehydrogenase from Equus caballus (HLADH)
and C-terminally His6-tagged pyruvate decarboxylase from Saccharomyces cerevisiae were kind gifts
from Bryce Plapp (University of Iowa) and Frank Jordan (Rutgers University), respectively. NADH,
IPTG, yeast alcohol dehydrogenase (YADH), and the various 2-keto acids were purchased from
Sigma-Aldrich (St Louis, MO, USA). Other assay reagents were purchased from either Sigma-Aldrich
or Fisher Scientific (Waltham, MA, USA) and were of the highest commercially available grade.
3.2. Protein Expression and Purification
Expression and purification of wtBFDC and the BFDC T377L/A460Y variant was carried out as
described in Yep et al. [30]. The protein was exchanged into storage buffer (100 mM KPO4, 1 mM
MgSO4, 0.5 mM ThDP, pH 6.0, 10% glycerol v/v), and concentrated using EMD Millipore Amicon Ultra
filters (Fisher Scientific). Expression and purification of ScPDC was carried out in a similar manner.
In all cases purity was assessed by SDS-PAGE, and the protein concentration was determined by the
Bradford method [53] using BSA as the standard.
3.3. Analysis of Substrate Spectrum
The activity assays with the purified enzymes have been described in detail elsewhere [30].
The assay contained the appropriate 2-keto acid substrate, NADH, and HLADH (YADH for short
straight-chain aliphatic substrates) in 100 mM potassium phosphate buffer (pH 6.0) with a final volume
of 1 mL. The reaction was carried out at 30 oC and was initiated by the addition of the enzyme. Kinetic
data were fitted to the Michaelis-Menten equation using SigmaPlot 9.0.1.
3.4. Steady State Analysis of Reaction Intermediates by Acid Quench/NMR Spectroscopy
Prior to the chemical quench/NMR studies, excess ThDP was removed from the BFDC
T377L/A460Y sample by dialysis overnight against 50 mM potassium phosphate buffer, pH 6.5,
supplemented with 2.5 mM MgSO4. Enzyme concentrations were adjusted to 15 mg/mL and reacted
with one equivalent volume of either 50 mM benzoylformate or 100 mM pyruvate prepared in the
same buffer as the enzyme. After 1–10 seconds the reaction was quenched by manual mixing with the
addition of 1 volume of an acidic solution comprising 65% (v/v) D2O, 25% (v/v) of trichloroacetic acid
and 10% (v/v) concentrated HCl [24,25]. Samples were vortexed to facilitate complete quenching and
protein denaturation. Samples were then centrifuged and the supernatant passed through a 0.22 µm
filter. The filtrate, containing the intermediates, substrates and products, was analyzed by 1H NMR
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spectroscopy. NMR data collection, assignment of peaks, and calculation of net forward unimolecular
rate constants was performed as previously described [24,25].
3.5. Crystallization of BFDC T377L/A460Y
Crystals of the BFDC T377L/A460Y variant were grown by the hanging drop diffusion method
under the conditions used for the crystallization of wtBFDC [17]. Storage buffer was exchanged for
crystallization buffer (0.1 mM MgCl2, 0.2 mM ThDP, 25 mM NaHEPES pH 7.0). The well solution
consisted of 0.1 M Tris (pH 8.5), 0.15 M CaCl2 and 22% PEG 400 (v/v). Equal volumes of protein
solution (10 mg/mL) and well solution were pipetted onto a silanized glass slide and mixed. A heavy
precipitate quickly formed and single crystals emerged from the precipitate within days. Crystals
were transferred to fresh crystallization buffer containing 36% glycerol (v/v) as a cryoprotectant and
mounted on Hampton CryoLoops immediately prior to being flash-frozen in liquid nitrogen.
3.6. X-ray Data Collection
Diffraction experiments were carried out at 100 K on the 23-ID-B beamline administered by
GM/CA-CAT at the Advanced Photon Source at Argonne National Laboratory. Datasets for the
BFDC T377L/A460Y variant were scaled to the I222 space group. Data reduction and processing of
dataset was done with HKL2000 software package and the CCP4 suite of programs [54]. Molecular
replacement was performed using the search model wtBFDC (PDB 1BFD) with metals and waters
removed. The asymmetric unit for each variant contained a single monomer.
3.7. Structure Solutions and Refinements
Refinement was performed using Phenix.refine [55]. After each round of refinement, the
electron density was manually inspected and models were built using Coot [56]. Model refinement
continued until the free R factor and the crystallographic R factor had converged. Validity of the
model was checked using the Molprobity server [57,58]. All images were generated with PyMOL
(Schrödinger Inc.).
3.8. Modeling of Reaction Analogues and Intermediates
Using PyMOL and the coordinates from PDB ID 3OE1, the lactyl-ThDP intermediate was placed
into the active sites of both wtBFDC (PDB ID: 1BFD) and the T377L/A460Y structure. Further, using
the coordinates from PDB ID 3FZN, the phosphonomandelyl-ThDP (MBP-ThDP) was also placed
into the active site of the T377L/A460Y structure. In this process, the Cα atoms of the protein
structures were first superimposed. Next, the atoms corresponding to the ThDP moiety of lactyl-ThDP
and MBP-ThDP were aligned with the corresponding atoms of either ThDP, found in wtBFDC,
or the thiamin thiazolone diphosphate (TZD) found in the BFDC T377L/A460Y structure. No energy
minimization was carried out.
4. Conclusions
The BFDC variant T377L/A460Y effectively acts as a “pseudo” PDC. This is reflected in a
broad substrate spectrum more akin to that of ScPDC than wtBFDC. NMR-based analysis of the
steady-state reaction intermediates for the reaction of BFDC T377L/A460Y with pyruvate revealed
that the rate-limiting step for this variant is the formation of the LThDP intermediate. This is in
contrast to the reactions catalyzed by ZmPDC and ScPDC, where product release is rate-limiting.
Comparing the methyl-binding pocket of T377L/A460Y to ZmPDC suggests that both are likely to
have a similar number of interactions with the lactyl moiety. However, the contacts within the ZmPDC
methyl-binding pocket are evenly distributed across seven residues compared to only four residues
in T377L/A460Y. Further, the seven residues of ZmPDC are arranged to surround the methyl group
thereby providing steric restraints from every direction. Presumably this arrangement would also
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allow for the maximum orbital overlap, thereby permitting attack of the ThDP ylid and facilititating
the subsequent decarboxylation of the LThDP intermediate. On the other hand, the four residues
comprising the T377L/A460Y methyl binding pocket are unevenly arranged and do not provide the
precise substrate positioning seen in a native PDC. This likely accounts for the higher Km value for
pyruvate, and the lower rate of formation of LThDP observed with the BFDC variant. Given that
several aliphatic 2-keto acids are better substrates than pyruvate for T377L/A460Y, it is reasonable to
predict that further evolution could well bring the properties of the “pseudo” PDC significantly closer
to those of the native enzyme.
Over the years there have been many attempts to interconvert or otherwise alter substrate
specificity in ThDP-dependent enzymes. This has been met with a resounding lack of success [1].
The results here provide some rationale for the difficulty. They highlight the fact that, in spite of the
similarity in overall mechanism, ThDP-dependent enzymes often have different rate-determining
steps. This means that the enzymes have evolved so that individual residues will provide an optimal
alignment for (effectively) several substrates (intermediates) in the catalytic cycle. Thus, making a
change that may be expected to improve binding for a new substrate may have a deleterious effect
on another step in the mechanism. In the BFDC T377L/A460Y variant, for example, not only do we
see a new ability to catalyze pyruvate decarboxylation, but it is done without greatly affecting its
ability to bind benzoylformate. Rather, the decrease in kcat value for reaction with benzoylformate is
due primarily to a change in rate-determining step. This result implies that structure-based redesign
of ThDP-dependent enzymes will prove difficult. Rather, a more random approach will be required,
probably involving saturation mutagenesis at a combination of sites identified on the basis of X-ray
structures or homology models.
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